(19)

(11)

EP 3 285 877 A1

(12)

(43) Date of publication: 28.02.2018 Bulletin 2018/09 (21) Application number: 16782737.7 (22) Date of filing: 21.04.2016

(51) International Patent Classification (IPC):  A61P 37/06(2006.01) A61K 35/15(2015.01) A61K 35/17(2015.01) (86) International application number: PCT/IL2016/050430 (87) International publication number: WO 2016/170541 (27.10.2016 Gazette 2016/43)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: MA MD (30) Priority: 21.04.2015 US 201562150305 P (71) Applicant: Enlivex Therapeutics Ltd. 91120 Jerusalem (IL)	(72) Inventors: MEVORACH, Dror 95744 Jerusalem (IL) NOVIK, Shai 47212 Ramat Hasharon (IL) (74) Representative: Pearl Cohen Zedek Latzer Baratz UK LLP  16 Upper Woburn Place London WC1H 0BS London WC1H 0BS (GB)